首站-论文投稿智能助手
典型文献
Association between the Neutrophil-to-lymphocyte Ratio and New-onset Subclinical Macrovascular and Microvascular Diseases in the Chinese Population
文献摘要:
Objective The association between neutrophil-to-lymphocyte ratio (NLR) with subclinicalmacrovascular and microvascular diseases has been less investigated. We sought to examine theassociation between NLR and new-onset subclinical macrovascular and microvascular abnormalities inthe Chinese population. Methods From a community cohort, we included 6,430 adults aged ≥ 40 years without subclinical macrovascular and microvascular diseases at baseline. We measured subclinical macrovascular andmicrovascular abnormalities separately using the ankle-brachial index (ABI), brachial-ankle pulse wave velocity (baPWV), and albuminuria. Results During a mean follow-up of 4.3 years, 110 participants developed incident abnormal ABI, 746 participants developed incident elevated baPWV, and 503 participants developed incident albuminuria. Poisson regression analysis indicated that NLR was significantly associated with an increased risk of new-onset abnormal ABI, elevated baPWV, and albuminuria. Compared to overweight/obese participants, we found a much stronger association between NLR and subclinical vascular abnormalities in participantswith normal weight. Furthermore, we found an interaction between the NLR and body mass index (BMI) on the risk of new-onset abnormal ABI (P for interaction: 0.01). Conclusion NLR was associated with subclinical macrovascular and microvascular diseases in theChinese population. Furthermore, in participants with normal weight, the association between NLR and subclinical vascular abnormalities was much stronger.
文献关键词:
作者姓名:
WANG Jia Lu;CAO Qiu Yu;XIN Zhuo Jun;LIU Shan Shan;XU Min;WANG Tian Ge;LU Jie Li;CHEN Yu Hong;WANG Shuang Yuan;ZHAO Zhi Yun;XU Yu;NING Guang;WANG Wei Qing;BI Yu Fang;LI Mian
作者机构:
Department of Endocrine and Metabolic Diseases,Shanghai Institute of Endocrine and Metabolic Diseases,RuijinHospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai NationalClinical Research Center for Metabolic Diseases,Key Laboratory for Endocrine and Metabolic Diseases of theNational Health Commission of the PR China,Shanghai Key Laboratory for Endocrine Tumor,State Key Laboratoryof Medical Genomics,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
引用格式:
[1]WANG Jia Lu;CAO Qiu Yu;XIN Zhuo Jun;LIU Shan Shan;XU Min;WANG Tian Ge;LU Jie Li;CHEN Yu Hong;WANG Shuang Yuan;ZHAO Zhi Yun;XU Yu;NING Guang;WANG Wei Qing;BI Yu Fang;LI Mian-.Association between the Neutrophil-to-lymphocyte Ratio and New-onset Subclinical Macrovascular and Microvascular Diseases in the Chinese Population)[J].生物医学与环境科学(英文版),2022(01):4-12
A类:
Macrovascular,subclinicalmacrovascular,theassociation,andmicrovascular,participantswith,theChinese
B类:
Association,between,Neutrophil,lymphocyte,Ratio,New,onset,Subclinical,Microvascular,Diseases,Population,Objective,neutrophil,ratio,NLR,diseases,has,been,less,investigated,We,sought,examine,new,abnormalities,inthe,population,Methods,From,community,cohort,included,adults,aged,years,without,baseline,measured,separately,using,ankle,brachial,ABI,pulse,wave,velocity,baPWV,albuminuria,Results,During,mean,follow,up,developed,incident,elevated,Poisson,regression,analysis,indicated,that,was,significantly,associated,increased,risk,Compared,overweight,obese,found,much,stronger,Furthermore,interaction,body,mass,Conclusion
AB值:
0.390601
相似文献
Association Between Lipid Profiles and Left Ventricular Hypertrophy: New Evidence from a Retrospective Study
Xuewei Huang;Keqiong Deng;Juanjuan Qin;Fang Lei;Xingyuan Zhang;Wenxin Wang;Lijin Lin;Yuming Zheng;Dongai Yao;Huiming Lu;Feng Liu;Lidong Chen;Guilan Zhang;Yueping Liu;Qiongyu Yang;Jingjing Cai;Zhigang She;Hongliang Li-Department of Cardiology,Renmin Hospital of Wuhan University,Wuhan 430060,China;Physical Examination Center,Zhongnan Hospital of Wuhan University,Wuhan 430071,China;Department of Cardiology,Center Hospital of Huanggang,Huanggang,Hubei 438000,China;Huanggang Institute of Translation Medicine,Huanggang,Hubei 438000,China;Department of Cardiology;Institute of Model Animal;School of Basic Medical Science,Wuhan University,Wuhan 430071,China;Physical Examination Center,The Central Hospital of Wuhan,Wuhan 430014,China;General Medical Department,CR&WISCO General Hospital,Wuhan 430000,China;Information Center,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Wuhan 430015,China;Department of Medical Examination Center,Taihe Hospital,Hubei University of Medicine,Shiyan,Hubei 442000,China;Department of Health Management,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology,Xiaogan,Hubei 432000,China;Basic Medical Laboratory,General Hospital of Central Theater Command,Wuhan 430070,China;Hubei Key Laboratory of Central Nervous System Tumor and Intervention,Wuhan 430070,China;Chinese Medicine Center,Shiyan Renmin Hospital,Shiyan,Hubei 442000,China;Department of Cardiology,The Third Xiangya Hospital,Central South University,Changsha 410000,China
Association between time in range and cancer mortality among patients with type 2 diabetes: a prospective cohort study
Shen Yun;Wang Chunfang;Wang Yaxin;Lu Jingyi;Chen Lei;Zhang Lei;Lu Wei;Zhu Wei;Hu Gang;Xia Tian;Zhou Jian-Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai 200233, China;Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA;Division of Vital Statistics, Institute of Health Information, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China;Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
Role of blood pressure on stroke-related mortality: a 45-year follow-up study in China
Wang Shengshu;Yang Shanshan;Jia Wangping;Han Ke;Song Yang;Zeng Jing;Cao Wenzhe;Liu Shaohua;Chen Shimin;Li Zhiqiang;Li Xuehang;Tai Penggang;Kou Fuyin;He Yao;Liu Miao-Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China;Department of Healthcare, Agency for Offices Administration, Central Military Commission, Beijing 100082, China;Department of Disease Prevention and Control, The 1st Medical Center, Chinese PLA General Hospital, Beijing 100853, China;Department of Endocrinology, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China;Department of Medical Service, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Epidemiology, State Key Laboratory of Kidney Diseases, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Graduate School of Chinese PLA General Hospital, Beijing 100853, China
Multimorbidity patterns and association with mortality in 0.5 million Chinese adults
Fan Junning;Sun Zhijia;Yu Canqing;Guo Yu;Pei Pei;Yang Ling;Chen Yiping;Du Huaidong;Sun Dianjianyi;Pang Yuanjie;Zhang Jun;Gilbert Simon;Avery Daniel;Chen Junshi;Chen Zhengming;Lyu Jun;Li Liming-Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China;Peking University Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing 100191, China;National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;China Kadoorie Biobank National Coordination Centre, Chinese Academy of Medical Sciences, Beijing 100730, China;Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, United Kingdom;Nuffield Department of Population Health, University of Oxford, Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Oxford OX3 7LF, United Kingdom;Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215004, China;China National Center for Food Safety Risk Assessment, Beijing 100022, China;Key Laboratory of Molecular Cardiovascular Sciences, Peking University, Ministry of Education, Beijing 100191, China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Associations of muscle mass, strength, and quality with all-cause mortality in China: a population-based cohort study
Wu Man;Wei Yuxia;Lv Jun;Guo Yu;Pei Pei;Li Jiachen;Du Huaidong;Yang Ling;Chen Yiping;Sun Xiaohui;Zhang Hua;Chen Junshi;Chen Zhengming;Yu Canqing;Li Liming;on behalf of the China Kadoorie Biobank Collaborative Group-Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China;Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing 100191, China;Peking University Center for Public Health and Epidemic Preparedness & Responses, Beijing 100191, China;National Coordinating Center of China Kadoorie Biobank, Chinese Academy of Medical Sciences, Beijing 102308, China;Medical Research Council Population Health Research Unit, the University of Oxford, Oxford OX3 7LF, UK;Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK;NCDs Prevention and Control Department, Qingdao CDC, Qingdao, Shandong 266033, China;NHC Key Laboratory of Food Safety Risk Assessment, China National Center for Food Safety Risk Assessment, Beijing 100022, China
Association of low cadmium and mercury exposure with chronic kidney disease among Chinese adults aged ≥80 years: A cross-sectional study
Wei Yuan;Lyu Yuebin;Cao Zhaojin;Zhao Feng;Liu Yingchun;Chen Chen;Li Chengcheng;Gu Heng;Lu Feng;Zhou Jinhui;Wu Bing;Liu Yang;Li Juan;Shi Xiaoming-China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China;Department of Hygienic Inspection, School of Public Health, Jilin University, Changchun, Jilin 130021, China;Beijing Municipal Health Commission Information Center, Beijing Municipal Health Commission Policy Research Center, Beijing 100034, China;Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin 130021, China
Laboratory Safety of Dupilumab, and Its Effect on Inflammatory Biomarkers, in Chinese Adults With Moderate-to-Severe Atopic Dermatitis: An Analysis of a Randomized, Double-Blind Phase III Study
Zhao Yan;Wu Li-Ming;Lu Qian-Jin;Gao Xing-Hua;Zhu Xiao-Hong;Yao Xu;Li Lin-Feng;Li Wei;Ding Yang-Feng;Song Zhi-Qiang;Liu Ling-Ling;Dang Ning-Ning;Zhang Chun-Lei;Liu Xiao-Ming;Gu Jun;Wang Jin-Yan;Geng Song-Mei;Liu Quan-Zhong;Guo Yi-Feng;Dong Li;Li Shelley;Xu Christine;O’Malley John T.;Laws Elizabeth;Amin Nikhil;Bansal Ashish;Wang Min;Zhang Jian-Zhong-Department of Dermatology, Peking University People’s Hospital, Beijing 100044, China;Hangzhou First People’s Hospital, Hangzhou, Zhejiang 310006, China;The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China;The First Hospital of China Medical University, Shenyang, Liaoning 110001, China;Wuxi Second People’s Hospital, Wuxi, Jiangsu 214002, China;Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210042, China;Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Huashan Hospital, Fudan University, Shanghai 200040, China;Shanghai Skin Disease Hospital, Shanghai 200040, China;The Southwest Hospital of AMU, Chongqing 400038, China;Peking University First Hospital, Beijing 100034, China;Jinan Central Hospital, Jinan, Shandong 250013, China;Peking University Third Hospital, Beijing 100191, China;University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong 518040, China;Changhai Hospital of Shanghai, Shanghai 200433, China;Ningbo No. 2 Hospital, Ningbo, Zhejiang 315099, China;The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710004, China;Tianjin Medical University General Hospital, Tianjin 300052, China;Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China;Research & Development, Sanofi, Bridgewater, NJ 08807, USA; Development, Regeneron, Tarrytown, NY 10591, USA;Medical, Sanofi China, Shanghai 200040, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。